Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist (UAB Core Center for Basic Skeletal Research).
Phase of Trial: Phase IV
Latest Information Update: 16 Jun 2017
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms CMBD
- 10 Jun 2017 Biomarkers information updated
- 19 May 2017 Status changed from completed to discontinued.
- 23 Dec 2016 Status changed from recruiting to completed.